MedTrace Logo

Dextrose Concentration Decline Rate in Vivo

NCT06128122 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2024-01-09

No results posted yet for this study

Summary

Measuring the speed of decrease in dextrose concentration to help design more accurate in vitro studies

Conditions

  • Dextrose Concentration

Interventions

PROCEDURE

Intrarticular and subcutaneous dextrose injection with timed measurement of dextrose levels

Step one: 30 mL of 12.5%/0.1% lidocaine will be injected into the knee using an inferomedial approach. Using ultrasound guidance, a 20-gauge 2-inch I.V. catheter will be placed in the suprapatellar pouch, by which samples of synovial fluid from the pouch will be withdrawn and analyzed for glucose level. Step two: 3 mL of D5W will be injected into a marked spot on the back of the upper arm. A sensor/transmitter (Dexcom G7 Dexcom) is placed at the site of injection. The sensor/transmitter will begin providing dextrose levels at 5 minute intervals beginning one-half hour after placement of the sensor/transmitter, transmitted to a paired smart phone.

Sponsors & Collaborators

  • Dr. Dean Reeves Clinic

    lead OTHER

Principal Investigators

  • Kenneth D Reeves, M.D. · Dr. Dean Reeves Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
69 Years
Max Age
69 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-19
Primary Completion
2024-01-04
Completion
2024-01-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06128122 on ClinicalTrials.gov